Karyopharm Therapeutics is an innovation-driven pharmaceutical company focused on the discovery, development, and commercialization of medicines with the goal of improving the lives of patients with cancer.
Our company was founded in 2008 with a vision of pioneering a potentially new approach to treating patients with cancer and other serious diseases.
Our novel approach to cancer treatment involves targeting the export of specific proteins in a cancer cell’s nucleus with SINE technology (Selective Inhibition of Nuclear Export).
Our primary focus is on developing novel drugs which we hope will help treat patients with certain blood cancers or solid tumor malignancies. ( www.karyopharm.com )
Patient Support Center
1 877 KARY4WD (1 877 527 9493)
|Access Date||Quiz Result||Score||Actions|
Please make sure the password is typed in ALL CAPS and includes the exclamation point. Enter the email address that you used to register for the conference.